What did @misstealjedi1 actually say?
Honestly? Not much that can be fact-checked. The transcript captured here is song lyrics, not health claims. The words "slits in the face, all I want for you" appear to be audio from a trending sound, not original spoken content about GLP-1 medications or weight loss.
What we do have is context: the caption reads "It's progress" with a heart emoji, paired with hashtags including #glp1, #zepboundcommunity, and #glp1forweightloss. The video likely shows a visual progress update, a before-and-after style clip, or a body transformation moment set to music. That format is extremely common in the Zepbound community on TikTok, where users document their weight loss journeys without making explicit medical claims.
So there are no direct spoken health claims to fact-check here. What we can do is look at what this type of content implies and whether those implications hold up.
Does the science back this up?
If the implicit claim is that tirzepatide (Zepbound) produces meaningful, visible weight loss progress, yes, the evidence is strong. This is one of the better-supported outcomes in recent obesity medicine research.
The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) followed 2,539 adults with obesity over 72 weeks. Participants on the highest dose of tirzepatide (15 mg) lost an average of 20.9% of their body weight. That is not a rounding error. For context, earlier GLP-1 agents like liraglutide produced roughly 5-8% weight loss in comparable trials.
Progress posts like this one, showing incremental change over weeks or months, align with how tirzepatide actually works. It is not a fast drug. Most users see gradual loss over a year or more, with results varying significantly by dose, diet, and individual metabolism. The "progress" framing is clinically reasonable.
What did they get wrong (or right)?
There are no explicit claims to flag as wrong here, which is actually worth noting. A lot of GLP-1 content on TikTok overclaims: people say things like "this cured my food noise" or "I stopped taking insulin" without context. This post does not appear to do that.
What the content does right is keep it personal. "It's progress" is not a medical claim. It is a personal update. That kind of framing avoids the trap many creators fall into, positioning their individual experience as universal or prescriptive.
The one mild concern is the hashtag #glp1forweightloss, which lumps multiple drugs together. GLP-1 receptor agonists vary significantly in their mechanisms and outcomes. Tirzepatide is a dual GIP/GLP-1 agonist, not a pure GLP-1 drug. Semaglutide, liraglutide, and tirzepatide are not interchangeable, and content that implies they are does a disservice to people trying to understand their options.
What should you actually know?
Progress on GLP-1 or dual-agonist medications is real, documented, and for many people, significant. But a few things often get lost in the scroll.
- Weight loss results vary widely. SURMOUNT-1 showed a range from minimal loss to over 25% body weight reduction. The average is not everyone's experience.
- These medications require ongoing use. Wilding et al. (2022, Diabetes, Obesity and Metabolism) showed that stopping semaglutide led to regain of roughly two-thirds of lost weight within a year.
- Side effects are common, especially early on. Nausea, vomiting, and GI discomfort affect a significant portion of users, particularly during dose escalation.
- Compounded versions of these drugs are not equivalent to brand-name Zepbound or Wegovy. Formulation, inactive ingredients, and quality controls differ. Do not assume a compounded tirzepatide produces the same result as the FDA-approved product.
- Progress posts are motivating but not medical advice. What worked for one person on one dose at one point in their journey is not a template.
If you are considering a GLP-1 or dual-agonist medication, talk to a licensed provider who can review your full health history, not just your TikTok feed.